nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—peripheral nervous system neoplasm	0.562	1	CbGaD
Scopolamine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0534	0.239	CbGbCtD
Scopolamine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0534	0.239	CbGbCtD
Scopolamine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.037	0.166	CbGbCtD
Scopolamine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0228	0.102	CbGbCtD
Scopolamine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0213	0.0953	CbGbCtD
Scopolamine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0209	0.0937	CbGbCtD
Scopolamine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0143	0.0639	CbGbCtD
Scopolamine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000507	0.00241	CcSEcCtD
Scopolamine—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000506	0.0024	CcSEcCtD
Scopolamine—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000502	0.00239	CcSEcCtD
Scopolamine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000501	0.00238	CcSEcCtD
Scopolamine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000501	0.00238	CcSEcCtD
Scopolamine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000493	0.00235	CcSEcCtD
Scopolamine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.00234	CcSEcCtD
Scopolamine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00233	CcSEcCtD
Scopolamine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00049	0.00233	CcSEcCtD
Scopolamine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000486	0.00231	CcSEcCtD
Scopolamine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000486	0.00231	CcSEcCtD
Scopolamine—Pain—Topotecan—peripheral nervous system neoplasm	0.000486	0.00231	CcSEcCtD
Scopolamine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000486	0.00231	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.000484	0.0023	CcSEcCtD
Scopolamine—Pain—Tretinoin—peripheral nervous system neoplasm	0.000482	0.00229	CcSEcCtD
Scopolamine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000482	0.00229	CcSEcCtD
Scopolamine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000482	0.00229	CcSEcCtD
Scopolamine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000482	0.00229	CcSEcCtD
Scopolamine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.00229	CcSEcCtD
Scopolamine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000479	0.00228	CcSEcCtD
Scopolamine—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000478	0.00227	CcSEcCtD
Scopolamine—Pain—Melphalan—peripheral nervous system neoplasm	0.000475	0.00226	CcSEcCtD
Scopolamine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000475	0.00226	CcSEcCtD
Scopolamine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000468	0.00222	CcSEcCtD
Scopolamine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000464	0.00221	CcSEcCtD
Scopolamine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000464	0.00221	CcSEcCtD
Scopolamine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000463	0.0022	CcSEcCtD
Scopolamine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000463	0.0022	CcSEcCtD
Scopolamine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00046	0.00219	CcSEcCtD
Scopolamine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00046	0.00219	CcSEcCtD
Scopolamine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000457	0.00217	CcSEcCtD
Scopolamine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000453	0.00215	CcSEcCtD
Scopolamine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000449	0.00213	CcSEcCtD
Scopolamine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000449	0.00213	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.00213	CcSEcCtD
Scopolamine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000446	0.00212	CcSEcCtD
Scopolamine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000445	0.00212	CcSEcCtD
Scopolamine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000445	0.00212	CcSEcCtD
Scopolamine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000445	0.00212	CcSEcCtD
Scopolamine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000445	0.00212	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.0021	CcSEcCtD
Scopolamine—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000438	0.00208	CcSEcCtD
Scopolamine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.00207	CcSEcCtD
Scopolamine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000435	0.00207	CcSEcCtD
Scopolamine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00043	0.00205	CcSEcCtD
Scopolamine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000427	0.00203	CcSEcCtD
Scopolamine—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000423	0.00201	CcSEcCtD
Scopolamine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00042	0.002	CcSEcCtD
Scopolamine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.00199	CcSEcCtD
Scopolamine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000418	0.00199	CcSEcCtD
Scopolamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00198	CcSEcCtD
Scopolamine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00197	CcSEcCtD
Scopolamine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.00196	CcSEcCtD
Scopolamine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000411	0.00196	CcSEcCtD
Scopolamine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000407	0.00194	CcSEcCtD
Scopolamine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000404	0.00192	CcSEcCtD
Scopolamine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000404	0.00192	CcSEcCtD
Scopolamine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000403	0.00192	CcSEcCtD
Scopolamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000402	0.00191	CcSEcCtD
Scopolamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000399	0.0019	CcSEcCtD
Scopolamine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.0019	CcSEcCtD
Scopolamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000399	0.00189	CcSEcCtD
Scopolamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000399	0.00189	CcSEcCtD
Scopolamine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000398	0.00189	CcSEcCtD
Scopolamine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000397	0.00189	CcSEcCtD
Scopolamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000394	0.00187	CcSEcCtD
Scopolamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000393	0.00187	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.00186	CcSEcCtD
Scopolamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000384	0.00183	CcSEcCtD
Scopolamine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.0018	CcSEcCtD
Scopolamine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000379	0.0018	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000377	0.00179	CcSEcCtD
Scopolamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000375	0.00179	CcSEcCtD
Scopolamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000372	0.00177	CcSEcCtD
Scopolamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000372	0.00177	CcSEcCtD
Scopolamine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.00175	CcSEcCtD
Scopolamine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000367	0.00174	CcSEcCtD
Scopolamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00174	CcSEcCtD
Scopolamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00174	CcSEcCtD
Scopolamine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.00173	CcSEcCtD
Scopolamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.00173	CcSEcCtD
Scopolamine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000364	0.00173	CcSEcCtD
Scopolamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000361	0.00172	CcSEcCtD
Scopolamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.0017	CcSEcCtD
Scopolamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000358	0.0017	CcSEcCtD
Scopolamine—Rash—Topotecan—peripheral nervous system neoplasm	0.000358	0.0017	CcSEcCtD
Scopolamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000358	0.0017	CcSEcCtD
Scopolamine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000357	0.0017	CcSEcCtD
Scopolamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000356	0.00169	CcSEcCtD
Scopolamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000355	0.00169	CcSEcCtD
Scopolamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000355	0.00169	CcSEcCtD
Scopolamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000355	0.00169	CcSEcCtD
Scopolamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000355	0.00169	CcSEcCtD
Scopolamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000355	0.00169	CcSEcCtD
Scopolamine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000355	0.00169	CcSEcCtD
Scopolamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000353	0.00168	CcSEcCtD
Scopolamine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000353	0.00168	CcSEcCtD
Scopolamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000353	0.00168	CcSEcCtD
Scopolamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000353	0.00168	CcSEcCtD
Scopolamine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.00167	CcSEcCtD
Scopolamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000352	0.00167	CcSEcCtD
Scopolamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000352	0.00167	CcSEcCtD
Scopolamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000352	0.00167	CcSEcCtD
Scopolamine—Rash—Melphalan—peripheral nervous system neoplasm	0.000351	0.00167	CcSEcCtD
Scopolamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00035	0.00167	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000348	0.00166	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000345	0.00164	CcSEcCtD
Scopolamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00034	0.00162	CcSEcCtD
Scopolamine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.0016	CcSEcCtD
Scopolamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.0016	CcSEcCtD
Scopolamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000337	0.0016	CcSEcCtD
Scopolamine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000336	0.0016	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000335	0.00159	CcSEcCtD
Scopolamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000335	0.00159	CcSEcCtD
Scopolamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000335	0.00159	CcSEcCtD
Scopolamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00033	0.00157	CcSEcCtD
Scopolamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00033	0.00157	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00156	CcSEcCtD
Scopolamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000325	0.00155	CcSEcCtD
Scopolamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000325	0.00155	CcSEcCtD
Scopolamine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000325	0.00155	CcSEcCtD
Scopolamine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000324	0.00154	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.00153	CcSEcCtD
Scopolamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000322	0.00153	CcSEcCtD
Scopolamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000311	0.00148	CcSEcCtD
Scopolamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000311	0.00148	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00147	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00146	CcSEcCtD
Scopolamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00146	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.00145	CcSEcCtD
Scopolamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.00144	CcSEcCtD
Scopolamine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.0003	0.00143	CcSEcCtD
Scopolamine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000296	0.00141	CcSEcCtD
Scopolamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000295	0.0014	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00139	CcSEcCtD
Scopolamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00139	CcSEcCtD
Scopolamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00029	0.00138	CcSEcCtD
Scopolamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000288	0.00137	CcSEcCtD
Scopolamine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000287	0.00137	CcSEcCtD
Scopolamine—Pain—Etoposide—peripheral nervous system neoplasm	0.000285	0.00135	CcSEcCtD
Scopolamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000285	0.00135	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00135	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00135	CcSEcCtD
Scopolamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000282	0.00134	CcSEcCtD
Scopolamine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00134	CcSEcCtD
Scopolamine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000275	0.00131	CcSEcCtD
Scopolamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000273	0.0013	CcSEcCtD
Scopolamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000272	0.00129	CcSEcCtD
Scopolamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00129	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00129	CcSEcCtD
Scopolamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.00128	CcSEcCtD
Scopolamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.00128	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00127	CcSEcCtD
Scopolamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00127	CcSEcCtD
Scopolamine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000263	0.00125	CcSEcCtD
Scopolamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000263	0.00125	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.00125	CcSEcCtD
Scopolamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000262	0.00124	CcSEcCtD
Scopolamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00124	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00124	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00124	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00123	CcSEcCtD
Scopolamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000259	0.00123	CcSEcCtD
Scopolamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000259	0.00123	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00123	CcSEcCtD
Scopolamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000258	0.00123	CcSEcCtD
Scopolamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.00121	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000253	0.0012	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00118	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00117	CcSEcCtD
Scopolamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000244	0.00116	CcSEcCtD
Scopolamine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00116	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00115	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00114	CcSEcCtD
Scopolamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000239	0.00114	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00113	CcSEcCtD
Scopolamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000236	0.00112	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000235	0.00112	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00111	CcSEcCtD
Scopolamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000231	0.0011	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00023	0.0011	CcSEcCtD
Scopolamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000229	0.00109	CcSEcCtD
Scopolamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000229	0.00109	CcSEcCtD
Scopolamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00109	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00108	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00107	CcSEcCtD
Scopolamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00022	0.00105	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00103	CcSEcCtD
Scopolamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000216	0.00103	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00103	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00101	CcSEcCtD
Scopolamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000212	0.00101	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00101	CcSEcCtD
Scopolamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00021	0.001	CcSEcCtD
Scopolamine—Rash—Etoposide—peripheral nervous system neoplasm	0.00021	0.000999	CcSEcCtD
Scopolamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00021	0.000998	CcSEcCtD
Scopolamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000209	0.000993	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000978	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000949	CcSEcCtD
Scopolamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000198	0.000941	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000925	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00092	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000906	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000905	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000896	CcSEcCtD
Scopolamine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000888	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000871	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000867	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000863	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000859	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000851	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000838	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00083	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000829	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000822	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000806	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000802	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000798	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000794	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00079	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000768	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000766	CcSEcCtD
Scopolamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00076	CcSEcCtD
Scopolamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00076	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000732	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000731	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000709	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000703	CcSEcCtD
Scopolamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000703	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000702	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000702	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000677	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00065	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00065	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000637	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000628	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00059	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000587	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000581	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000565	CcSEcCtD
Scopolamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00056	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000559	CcSEcCtD
Scopolamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000556	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000543	CcSEcCtD
Scopolamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000528	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000523	CcSEcCtD
Scopolamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000518	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000518	CcSEcCtD
Scopolamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000515	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000488	CcSEcCtD
Scopolamine—CHRM3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.29e-05	0.00503	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.27e-05	0.00498	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	2.21e-05	0.00486	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.2e-05	0.00484	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.19e-05	0.00482	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.17e-05	0.00478	CbGpPWpGaD
Scopolamine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.14e-05	0.00472	CbGpPWpGaD
Scopolamine—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.14e-05	0.0047	CbGpPWpGaD
Scopolamine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.12e-05	0.00466	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	2.07e-05	0.00455	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	2.04e-05	0.0045	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	2.04e-05	0.00448	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	2.04e-05	0.00448	CbGpPWpGaD
Scopolamine—SI—Metabolism—GNAS—peripheral nervous system neoplasm	2.01e-05	0.00442	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	2.01e-05	0.00442	CbGpPWpGaD
Scopolamine—SI—Metabolism—ABCB1—peripheral nervous system neoplasm	1.97e-05	0.00434	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.92e-05	0.00423	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.92e-05	0.00423	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.84e-05	0.00405	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	1.84e-05	0.00405	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	1.83e-05	0.00402	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	1.82e-05	0.00401	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.75e-05	0.00384	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.7e-05	0.00374	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	1.68e-05	0.0037	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.67e-05	0.00368	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.67e-05	0.00368	CbGpPWpGaD
Scopolamine—SI—Disease—PTPN11—peripheral nervous system neoplasm	1.67e-05	0.00367	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.6e-05	0.00353	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.58e-05	0.00347	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.53e-05	0.00336	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.47e-05	0.00323	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.46e-05	0.00322	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.46e-05	0.00321	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.4e-05	0.00307	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.35e-05	0.00298	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.35e-05	0.00297	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.34e-05	0.00294	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.34e-05	0.00294	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.33e-05	0.00292	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	1.33e-05	0.00292	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.32e-05	0.00291	CbGpPWpGaD
Scopolamine—SI—Disease—ERBB2—peripheral nervous system neoplasm	1.32e-05	0.0029	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.3e-05	0.00285	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.29e-05	0.00284	CbGpPWpGaD
Scopolamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.29e-05	0.00283	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.28e-05	0.00282	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.28e-05	0.00282	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	1.27e-05	0.0028	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.27e-05	0.00279	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.22e-05	0.00269	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.21e-05	0.00267	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.18e-05	0.00259	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.17e-05	0.00258	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.17e-05	0.00257	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.16e-05	0.00256	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.15e-05	0.00252	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.13e-05	0.00248	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.13e-05	0.00248	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.12e-05	0.00247	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.11e-05	0.00245	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.11e-05	0.00244	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.11e-05	0.00244	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.11e-05	0.00244	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.08e-05	0.00237	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.04e-05	0.00228	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.03e-05	0.00227	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.03e-05	0.00227	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.03e-05	0.00226	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.02e-05	0.00224	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.02e-05	0.00224	CbGpPWpGaD
Scopolamine—SI—Disease—NRAS—peripheral nervous system neoplasm	1e-05	0.00221	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.89e-06	0.00218	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.88e-06	0.00217	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.83e-06	0.00216	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.8e-06	0.00216	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.7e-06	0.00213	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	9.49e-06	0.00209	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.47e-06	0.00208	CbGpPWpGaD
Scopolamine—SI—Disease—MYC—peripheral nervous system neoplasm	9.34e-06	0.00206	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.02e-06	0.00198	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.99e-06	0.00198	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	8.96e-06	0.00197	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	8.93e-06	0.00196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.93e-06	0.00196	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.9e-06	0.00196	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.9e-06	0.00196	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	8.84e-06	0.00195	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.81e-06	0.00194	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.64e-06	0.0019	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GNS—peripheral nervous system neoplasm	8.29e-06	0.00182	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.28e-06	0.00182	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	8.24e-06	0.00181	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	8.21e-06	0.00181	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	8.13e-06	0.00179	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NME1—peripheral nervous system neoplasm	7.95e-06	0.00175	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.85e-06	0.00173	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.82e-06	0.00172	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—COX2—peripheral nervous system neoplasm	7.65e-06	0.00168	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.56e-06	0.00166	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.52e-06	0.00165	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.49e-06	0.00165	CbGpPWpGaD
Scopolamine—SI—Disease—HRAS—peripheral nervous system neoplasm	7.34e-06	0.00161	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.28e-06	0.0016	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.24e-06	0.00159	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.22e-06	0.00159	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	7.02e-06	0.00154	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.96e-06	0.00153	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.94e-06	0.00153	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.94e-06	0.00153	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.91e-06	0.00152	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.87e-06	0.00151	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.86e-06	0.00151	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.68e-06	0.00147	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.67e-06	0.00147	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.66e-06	0.00147	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.65e-06	0.00146	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.58e-06	0.00145	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.57e-06	0.00145	CbGpPWpGaD
Scopolamine—SI—Disease—AKT1—peripheral nervous system neoplasm	6.48e-06	0.00143	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	6.11e-06	0.00134	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.83e-06	0.00128	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.81e-06	0.00128	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.75e-06	0.00127	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.54e-06	0.00122	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.49e-06	0.00121	CbGpPWpGaD
Scopolamine—SI—Metabolism—AKT1—peripheral nervous system neoplasm	5.43e-06	0.00119	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.42e-06	0.00119	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.39e-06	0.00119	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.29e-06	0.00116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.28e-06	0.00116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.27e-06	0.00116	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	5.26e-06	0.00116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.26e-06	0.00116	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.22e-06	0.00115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.2e-06	0.00114	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.19e-06	0.00114	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.1e-06	0.00112	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.08e-06	0.00112	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	5.05e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.03e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	5.03e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.89e-06	0.00108	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.87e-06	0.00107	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.87e-06	0.00107	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	4.86e-06	0.00107	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.85e-06	0.00107	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.8e-06	0.00106	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.77e-06	0.00105	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.64e-06	0.00102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.63e-06	0.00102	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.61e-06	0.00101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.57e-06	0.001	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.57e-06	0.001	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.44e-06	0.000977	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.42e-06	0.000972	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.41e-06	0.000971	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.33e-06	0.000952	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	4.25e-06	0.000934	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.23e-06	0.000931	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.05e-06	0.000892	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.05e-06	0.000891	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	3.99e-06	0.000878	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.88e-06	0.000854	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.65e-06	0.000804	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.64e-06	0.000801	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.61e-06	0.000794	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.55e-06	0.000782	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	3.26e-06	0.000717	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.22e-06	0.000707	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.21e-06	0.000705	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.2e-06	0.000703	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.19e-06	0.000701	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.17e-06	0.000698	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.13e-06	0.000688	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.12e-06	0.000685	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.09e-06	0.000679	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3e-06	0.00066	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.98e-06	0.000655	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.97e-06	0.000653	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.94e-06	0.000647	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.87e-06	0.000631	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.82e-06	0.00062	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.75e-06	0.000604	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.73e-06	0.000601	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.72e-06	0.000599	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.7e-06	0.000594	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.7e-06	0.000593	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	2.69e-06	0.000593	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.57e-06	0.000565	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.53e-06	0.000557	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.23e-06	0.00049	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.13e-06	0.000469	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.1e-06	0.000461	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.07e-06	0.000455	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.04e-06	0.000449	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.02e-06	0.000445	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.01e-06	0.000442	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.95e-06	0.00043	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.94e-06	0.000426	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.93e-06	0.000425	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.93e-06	0.000424	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.91e-06	0.00042	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.9e-06	0.000418	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.89e-06	0.000417	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.88e-06	0.000413	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.85e-06	0.000407	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.77e-06	0.00039	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.69e-06	0.000373	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.62e-06	0.000357	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.58e-06	0.000347	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.51e-06	0.000332	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.5e-06	0.00033	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.5e-06	0.000329	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.48e-06	0.000326	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.41e-06	0.000311	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.41e-06	0.00031	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.4e-06	0.000307	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.38e-06	0.000303	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.37e-06	0.000302	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.36e-06	0.0003	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.36e-06	0.000299	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.36e-06	0.000299	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.35e-06	0.000296	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.3e-06	0.000285	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.25e-06	0.000275	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.25e-06	0.000274	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.24e-06	0.000273	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.24e-06	0.000273	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.23e-06	0.000271	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.19e-06	0.000261	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.14e-06	0.000251	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.14e-06	0.00025	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.13e-06	0.000248	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.09e-06	0.000241	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.06e-06	0.000234	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.06e-06	0.000233	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.05e-06	0.000231	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.05e-06	0.000231	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	8.8e-07	0.000193	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.74e-07	0.000192	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.71e-07	0.000192	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.63e-07	0.00019	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.36e-07	0.000184	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.33e-07	0.000183	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.25e-07	0.000181	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.38e-07	0.000162	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.36e-07	0.000162	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.28e-07	0.00016	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	5.58e-07	0.000123	CbGpPWpGaD
